NexImmune Inc. announced the appointment of Leena Gandhi, M.D., Ph.D., Director for the Center of Therapeutic Innovation at Dana-Farber Cancer Institute, to its Board of Directors as a Non-Executive Director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +0.35% | -9.38% | +30.63% |
05-20 | NexImmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-17 | North American Morning Briefing : Stock Futures -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+30.63% | 3.98M | |
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+5.15% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-14.62% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- NEXI Stock
- News NexImmune, Inc.
- NexImmune Inc. Appoints Leena Gandhi to Board of Directors as a Non-Executive Director